Rispond Plus-LS Tablet
By Rispond-Plus
Rx
10 Tablet in a Strip

Composition
Risperidone(2mg) + Trihexyphenidyl(2mg)

Manufacturer - Micro Labs Ltd
27, RACE COURSE ROAD, BANGALORE-560 001, INDIA

Expires on or after
July, 2026

liver
When using Rispond Plus-LS Tablet, it is important to exercise caution if you have liver disease. In such cases, dosage adjustment of the tablet may be necessary for your safety and well-being. It is highly advised to seek advice from your doctor regarding the appropriate usage of Rispond Plus-LS Tablet to ensure it is suitable for individuals with liver conditions.

kidney
Rispond Plus-LS Tablet should be used with caution in patients with kidney disease. Dose adjustment may be necessary. Kindly consult your doctor.

alcohol
Consuming alcohol with Rispond Plus-LS Tablet can lead to increased drowsiness. It is important to be cautious about alcohol intake when taking this medication.

driving
Caution should be taken when driving while using Rispond Plus-LS Tablet as it may cause blurring of vision, dizziness, mild nausea, and mental confusion, impacting driving ability.

pregnancy
Rispond Plus-LS Tablet is considered potentially unsafe during pregnancy. While human studies are limited, animal studies suggest possible harm to the developing baby. It's essential to consult with your doctor to assess the benefits and risks before using this medication.

breastfeeding
Rispond Plus-LS Tablet could be harmful during breastfeeding, as limited data indicates it may pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | NEURO CNS |
Action Class | - |
₹70
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024